Brief: Xspray Pharma Resolves On Rights Issue Of About SEK 130 Mln

Xspray Pharma publ AB

15/08/2025 06:59

Aug 15 (Reuters) - XSpray Pharma AB (publ) XSPRAY.ST:

RESOLVES ON RIGHTS ISSUE OF ABOUT SEK 130 MILLION WITH  OVER-ALLOTMENT ISSUE AND CARRIES OUT DEBT REFINANCING

RIGHTS ISSUE COULD INCREASE BY SEK 20 MILLION

REFINANCES LOAN WITH FENJA CAPITAL, EXTENDS MATURITY

REFINANCES SEK 100 MILLION LOAN, FENJA TAKES OVER

LOAN MATURITY EXTENDED BY 18 MONTHS, INCREASED BY SEK 25 MILLION

Source text: ID:nMFN5Cj1w4

Further company coverage: XSPRAY.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))